TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Pulmonary Edema Market, by Type
6.1 Introduction
6.2 Cardogenic Edema
Market Estimates & Forecast, 2020 – 2027
6.3 Cardogenic Edema
Market Estimates & Forecast, 2020 – 2027
6.4 Others
Chapter 7. Global Pulmonary Edema Market, by Diagnosis
7.1 Introduction
7.2 Blood Tests
Market Estimates & Forecast, 2020 – 2027
7.2.1 B-Type Natriuretic Peptide (BNP)
7.2.2 Blood Count Test
7.2.3 Kidney Function Test
7.2.4 Others
7.3 Imaging
Market Estimates & Forecast, 2020 – 2027
7.3.1 Chest X-ray
7.3.2 Electrocardiogram
7.3.3 Echocardiogram
7.3.4 Transesophageal Echocardiography
7.3.5 Pulse oximetry
7.3.6 Others
7.4 Others
Chapter 8. Global Pulmonary Edema Market, by Treatment
8.1 Introduction
8.2 Preload Reducers
Market Estimates & Forecast, 2020 – 2027
8.2.1 Nitroglycerin
8.2.2 Diuretics
8.2.3 Others
8.3 Morphine
Market Estimates & Forecast, 2020 – 2027
8.4 Suction Catheter
Market Estimates & Forecast, 2020 – 2027
8.5 Others
Chapter 9. Global Pulmonary Edema Market, by End User
9.1 Introduction
9.2 Hospitals & Clinics
Market Estimates & Forecast, 2020 – 2027
9.3 Academic Institutes
Market Estimates & Forecast, 2020 – 2027
9.4 Retail Pharmacies
Market Estimates & Forecast, 2020 – 2027
9.5 Others
Chapter 10. Global Pulmonary Edema Market, by Region
10.1 Introduction
10.2 America
10.2.1 North America
10.2.1.1 U.S.
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 U.K
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
Chapter 11. Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
Chapter 12 Company Profiles
12.1 Pfizer Inc.
12.1.1 Company Overview
12.1.2 Type Overview
12.1.3 Financials
12.2.4 Key Developments
12.1.5 SWOT Analysis
12.2 ARGON MEDICAL
12.2.1 Company Overview
12.2.2 Type Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Edwards Lifesciences Corporation
12.3.1 Company Overview
12.3.2 Type Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 BD
12.4.1 Company Overview
12.4.2 Type/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 Alcaliber S.A.
12.5.1 Company Overview
12.5.2 Type Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.6 Lupin Pharmaceuticals, Inc.
12.6.1 Company Overview
12.6.2 Type Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.7 Vitaltec Corporation
12.7.1 Overview
12.7.2 Type Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 Medtronic
12.8.1 Overview
12.8.2 Type Overview
12.8.3 Financials
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.9 Koninklijke Philips N.V.
12.9.1 Overview
12.9.2 Type Overview
12.9.3 Financials
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.10 Siemens Healthcare GmbH
12.10.1 Overview
12.10.2 Type Overview
12.10.3 Financials
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.11 Hitachi Medical Corporation
12.11.1 Overview
12.11.2 Type Overview
12.11.3 Financials
12.11.4 Key Developments
12.11.5 SWOT Analysis
12.12 CANON MEDICAL SYSTEMS CORPORATION
12.12.1 Overview
12.12.2 Type Overview
12.12.3 Financials
12.12.4 Key Developments
12.12.5 SWOT Analysis
12.13 Others
Chapter 13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEO’s View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Pulmonary Edema Market
Chapter 14 Appendix
LIST OF TABLES
Table 1 Pulmonary Edema Industry Synopsis, 2020 – 2027
Table 2 Global Pulmonary Edema Market Estimates and Forecast, 2020 – 2027, (USD Million)
Table 3 Global Pulmonary Edema Market by Region, 2020 – 2027, (USD Million)
Table 4 Global Pulmonary Edema Market by Types, 2020 – 2027, (USD Million)
Table 5 Global Pulmonary Edema Market by Diagnosis, 2020 – 2027, (USD Million)
Table 6 Global Pulmonary Edema Market by Treatment, 2020 – 2027, (USD Million)
Table 7 Global Pulmonary Edema Market by End User, 2020 – 2027, (USD Million
Table 8 North America Pulmonary Edema Market by Types, 2020 – 2027, (USD Million)
Table 9 North America Pulmonary Edema by Diagnosis, 2020 – 2027, (USD Million)
Table 10 North America Pulmonary Edema by Treatment, 2020 – 2027, (USD Million)
Table 11 North America Pulmonary Edema by End User, 2020 – 2027, (USD Million)
Table 12 U.S. Pulmonary Edema Market by Types, 2020 – 2027, (USD Million)
Table 13 U.S. Pulmonary Edema Market by Diagnosis, 2020 – 2027, (USD Million)
Table 14 U.S. Pulmonary Edema Market by Treatment, 2020 – 2027, (USD Million)
Table 15 U.S. Pulmonary Edema Market by End User, 2020 – 2027, (USD Million)
Table 16 Canada Pulmonary Edema Market by Types, 2020 – 2027, (USD Million)
Table 17 Canada Pulmonary Edema Market by Diagnosis, 2020 – 2027, (USD Million)
Table 18 Canada Pulmonary Edema Market by Treatment, 2020 – 2027, (USD Million)
Table 19 Canada Pulmonary Edema Market by End User, 2020 – 2027, (USD Million)
Table 20 South America Pulmonary Edema Market by Types, 2020 – 2027, (USD Million)
Table 21 South America Pulmonary Edema Market by Diagnosis, 2020 – 2027, (USD Million)
Table 22 South America Pulmonary Edema Market by Treatment, 2020 – 2027, (USD Million)
Table 23 South America Pulmonary Edema Market by End User, 2020 – 2027, (USD Million)
Table 24 Europe Pulmonary Edema Market by Types, 2020 – 2027, (USD Million)
Table 25 Europe Pulmonary Edema Market by Diagnosis, 2020 – 2027, (USD Million)
Table 26 Europe Pulmonary Edema Market by Treatment, 2020 – 2027, (USD Million)
Table 27 Europe Pulmonary Edema Market by End User, 2020 – 2027, (USD Million)
Table 28 Western Europe Pulmonary Edema Market by Types, 2020 – 2027, (USD Million)
Table 29 Western Europe Pulmonary Edema Market by Diagnosis, 2020 – 2027, (USD Million)
Table 30 Western Europe Pulmonary Edema Market by Treatment, 2020 – 2027, (USD Million)
Table 31 Western Europe Pulmonary Edema Market by End User, 2020 – 2027, (USD Million)
Table 32 Eastern Europe Pulmonary Edema Market by Types, 2020 – 2027, (USD Million)
Table 33 Eastern Europe Pulmonary Edema Market by Diagnosis, 2020 – 2027, (USD Million)
Table 34 Eastern Europe Pulmonary Edema Market by Treatment, 2020 – 2027, (USD Million)
Table 35 Eastern Europe Pulmonary Edema Market by End User, 2020 – 2027, (USD Million)
Table 36 Asia Pacific Pulmonary Edema Market by Types, 2020 – 2027, (USD Million)
Table 37 Asia Pacific Pulmonary Edema Market by Diagnosis, 2020 – 2027, (USD Million)
Table 38 Asia Pacific Pulmonary Edema Market by Treatment, 2020 – 2027, (USD Million)
Table 39 Asia Pacific Pulmonary Edema Market by End User, 2020 – 2027, (USD Million)
Table 40 The Middle East & Africa Pulmonary Edema Market by Types, 2020 – 2027, (USD Million)
Table 41 The Middle East & Africa Pulmonary Edema Market by Diagnosis, 2020 – 2027, (USD Million)
Table 42 The Middle East & Africa Pulmonary Edema Market by Treatment, 2020 – 2027, (USD Million)
Table 43 The Middle East & Africa Pulmonary Edema Market by End User, 2020 – 2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Pulmonary Edema Market
Figure 3 Market Dynamics for Global Pulmonary Edema Market
Figure 4 Global Pulmonary Edema Market Share, by Type 2020
Figure 5 Global Pulmonary Edema Market Share, by Diagnosis 2020
Figure 6 Global Pulmonary Edema Market Share, by Treatment, 2020
Figure 7 Global Pulmonary Edema Market Share, by End User, 2020
Figure 8 Global Pulmonary Edema Market Share, by Region, 2020
Figure 9 North America Pulmonary Edema Market Share, by Country, 2020
Figure 10 Europe Pulmonary Edema Market Share, by Country, 2020
Figure 11 Asia Pacific Pulmonary Edema Market Share, by Country, 2020
Figure 12 The Middle East & Africa Pulmonary Edema Market Share, by Country, 2020
Figure 13 Global Pulmonary Edema Market: Company Share Analysis, 2020 (%)
Figure 14 Pfizer Inc.: Key Financials
Figure 15 Pfizer Inc.: Segmental Revenue
Figure 16 Pfizer Inc.: Geographical Revenue
Figure 17 ARGON MEDICAL: Key Financials
Figure 18 ARGON MEDICAL: Segmental Revenue
Figure 19 ARGON MEDICAL: Geographical Revenue
Figure 20 Edwards Lifesciences Corporation: Key Financials
Figure 21 Edwards Lifesciences Corporation: Segmental Revenue
Figure 22 Edwards Lifesciences Corporation: Geographical Revenue
Figure 23 BD: Key Financials
Figure 24 BD: Segmental Revenue
Figure 25 BD: Geographical Revenue
Figure 26 Alcaliber S.A.: Key Financials
Figure 27 Alcaliber S.A.: Segmental Revenue
Figure 28 Alcaliber S.A.: Geographical Revenue
Figure 29 Lupin Pharmaceuticals, Inc.: Key Financials
Figure 30 Lupin Pharmaceuticals, Inc.: Segmental Revenue
Figure 31 Lupin Pharmaceuticals, Inc.: Geographical Revenue
Figure 32 Vitaltec Corporation: Key Financials
Figure 33 Vitaltec Corporation: Segmental Revenue
Figure 34 Vitaltec Corporation: Geographical Revenue
Figure 35 Medtronic: Key Financials
Figure 36 Medtronic: Segmental Revenue
Figure 37 Medtronic; Geographical Revenue
Figure 38 Koninklijke Philips N.V.: Key Financials
Figure 39 Koninklijke Philips N.V.: Segmental Revenue
Figure 40 Koninklijke Philips N.V.: Geographical Revenue
Figure 41 Siemens Healthcare GmbH: Key Financials
Figure 42 Siemens Healthcare GmbH: Segmental Revenue
Figure 43 Siemens Healthcare GmbH: Geographical Revenue
Figure 44 Hitachi Medical Corporation: Key Financials
Figure 45 Hitachi Medical Corporation: Segmental Revenue
Figure 46 Hitachi Medical Corporation: Geographical Revenue
Figure 47 CANON MEDICAL SYSTEMS CORPORATION: Key Financials
Figure 48 CANON MEDICAL SYSTEMS CORPORATION: Segmental Revenue
Figure 49 CANON MEDICAL SYSTEMS CORPORATION: Geographical Revenue
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
